What Happened?
Cranbury, NJ-based Rocket-Pharmaceuticals Appointed Christopher Herzog as Associate Vice President, AAV Research and Development
About the Company
Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company advancing numerous gene therapies that could cure rare childhood diseases. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for seeking gene therapy cures for devastating diseases and making a difference for patients. Become an integral part of a small, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. In addition to a competitive compensation package featuring a generous 401K match and stock options, positions include excellent health benefits.
About the Person
Christopher Herzog is Associate Vice President, AAV Research and Development at Rocket Pharmaceuticals. Previously, Christopher held various senior HR leadership roles in the industry.
Info Source
News
Short Profile